Ansell (ANN) Stock Overview
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
ANN Community Fair Values
Create NarrativeSee what 41 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
AU$34.1
FV
14.2% undervalued intrinsic discount8.95%
Revenue growth p.a.
65
users have viewed this narrative2users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Ansell Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$29.27 |
| 52 Week High | AU$37.54 |
| 52 Week Low | AU$25.05 |
| Beta | 0.56 |
| 1 Month Change | 13.85% |
| 3 Month Change | -1.61% |
| 1 Year Change | -4.72% |
| 3 Year Change | 11.59% |
| 5 Year Change | -30.46% |
| Change since IPO | 14.17% |
Recent News & Updates
Narrative Update • Mar 28
ANN: Sustainable Chemical Protection And Capital Returns Will Support Future Upside Potential
Analysts have nudged their fair value estimate for Ansell slightly lower, trimming the price target from about A$36.47 to A$36.23 as they refresh assumptions around discount rates, long term revenue growth, profit margins and the future P/E multiple. What's in the News Announced an interim dividend of US$0.266 per share for the six months ended December 31, 2025, with an ex date of February 23, 2026, record date of February 24, 2026, and payment date of March 13, 2026 (Key Developments).Narrative Update • Mar 09
ANN: Sustainable Chemical Protection And Capital Returns Will Support Future Margin And Pricing Power
Analysts have made a small upward adjustment to their Ansell valuation, with the fair value estimate nudging higher from about A$36.05 to around A$36.47. This reflects updated assumptions for the discount rate, revenue growth, profit margin and future P/E.
New Narrative • Mar 09
Overweight on ANN
My view: Ansell (ASX: ANN) is a quality, mid-risk company suited for a long-term investment. It operates within a stable and expanding TAM, supported by rising global safety and healthcare demand.Narrative Update • Feb 23
ANN: Chemical Protection And Sustainability Features Will Support Future Margin And Pricing Power
Analysts have slightly reduced their Ansell price target to A$36.05 from A$36.28. The adjustment reflects updated views that incorporate a lower assumed revenue growth rate, a moderately higher discount rate, and a slightly lower future P/E multiple, partly offset by a higher expected profit margin.Recent updates
Narrative Update • Mar 28
ANN: Sustainable Chemical Protection And Capital Returns Will Support Future Upside Potential
Analysts have nudged their fair value estimate for Ansell slightly lower, trimming the price target from about A$36.47 to A$36.23 as they refresh assumptions around discount rates, long term revenue growth, profit margins and the future P/E multiple. What's in the News Announced an interim dividend of US$0.266 per share for the six months ended December 31, 2025, with an ex date of February 23, 2026, record date of February 24, 2026, and payment date of March 13, 2026 (Key Developments).Narrative Update • Mar 09
ANN: Sustainable Chemical Protection And Capital Returns Will Support Future Margin And Pricing Power
Analysts have made a small upward adjustment to their Ansell valuation, with the fair value estimate nudging higher from about A$36.05 to around A$36.47. This reflects updated assumptions for the discount rate, revenue growth, profit margin and future P/E.New Narrative • Mar 09
Overweight on ANN
My view: Ansell (ASX: ANN) is a quality, mid-risk company suited for a long-term investment. It operates within a stable and expanding TAM, supported by rising global safety and healthcare demand.Narrative Update • Feb 23
ANN: Chemical Protection And Sustainability Features Will Support Future Margin And Pricing Power
Analysts have slightly reduced their Ansell price target to A$36.05 from A$36.28. The adjustment reflects updated views that incorporate a lower assumed revenue growth rate, a moderately higher discount rate, and a slightly lower future P/E multiple, partly offset by a higher expected profit margin.Narrative Update • Feb 09
ANN: Chemical Protection Focus And Sustainability Credentials Will Support Future Pricing Power
Analysts have nudged their fair value estimate for Ansell slightly lower to A$36.28 from A$36.44. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations.Narrative Update • Jan 25
ANN: Tariff Risks And Safety Studios Will Shape Fairly Balanced Future Pricing
Analysts have trimmed their price target for Ansell slightly, citing updated assumptions that include a marginally lower fair value estimate, a modestly reduced revenue growth outlook, a slightly lower discount rate, and a small uplift in projected profit margins and future P/E multiples. Valuation Changes Fair Value: trimmed slightly, moving from A$36.75 to A$36.44 per share.Narrative Update • Jan 11
ANN: Tariff Risks And New Safety Studios Will Shape Future Pricing
Analysts have nudged their fair value estimate for Ansell slightly higher to about A$36.75 from A$36.63. This reflects a view that the shares still look cheap relative to an unchanged A$39 Street target and that current pricing already factors in potential healthcare PPE tariff risks.Narrative Update • Dec 26
ANN: Tariff Outcomes And New Safety Studios Will Shape Future Discount
Analysts have modestly reduced their fair value estimate for Ansell to about A$36.63, from roughly A$36.97, as they factor in a slightly higher discount rate while still viewing the stock as attractively priced, given that its current market discount appears larger than the potential earnings impact of possible healthcare PPE tariffs. Analyst Commentary Analyst sentiment around Ansell has turned more constructive, with recent research highlighting a disconnect between the share price and the underlying earnings outlook, even after factoring in potential healthcare PPE tariffs.Analysis Article • Dec 19
Here's Why Ansell (ASX:ANN) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Narrative Update • Dec 11
ANN: Future Studio Expansion And Tariff Risks Will Shape Share Discount
Analysts have nudged their price target on Ansell slightly lower to about A$37 from roughly A$37.10, reflecting only minor model adjustments. They continue to view the stock as undervalued given that its current discount appears larger than the potential impact of tariffs on healthcare personal protective equipment.Analysis Article • Dec 04
Are Investors Undervaluing Ansell Limited (ASX:ANN) By 34%?
Key Insights Ansell's estimated fair value is AU$55.37 based on 2 Stage Free Cash Flow to Equity Ansell's AU$36.40...Narrative Update • Nov 27
ANN: Upgraded Outlook Will Balance Tariff Risks as Shares Remain Discounted
Analysts have maintained Ansell's price target at A$39.00. This reflects the view that the stock remains undervalued given its current discount relative to potential tariff risks.Narrative Update • Nov 11
ANN: Confidence Remains High Despite Tariff Risks and Buyback Initiative Ahead
Analysts have raised their price target for Ansell from A$36.41 to A$37.07. They cite continued confidence in the company's valuation despite industry-wide concerns about tariffs and modest improvements in revenue growth and profit margin projections.Narrative Update • Oct 28
Healthcare And PPE Market Potential Will Support Greater Share Price Upside
Narrative Update on Ansell Analysts have slightly reduced their fair value price target for Ansell from $36.77 to $36.41. They cite that despite unchanged forecasts and ongoing concerns over tariffs, the stock continues to appear undervalued based on current market conditions.Analysis Article • Oct 15
Slowing Rates Of Return At Ansell (ASX:ANN) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Narrative Update • Oct 14
Healthcare And PPE Demand Will Unlock New Markets
Analysts have raised their fair value estimate for Ansell from A$35.15 to A$36.77. They cited that the shares appear undervalued relative to forecast risks and the current discount in the stock price.Analysis Article • Sep 26
Ansell Limited's (ASX:ANN) Price In Tune With Earnings
Ansell Limited's ( ASX:ANN ) price-to-earnings (or "P/E") ratio of 30x might make it look like a sell right now...Narrative Update • Sep 17
Healthcare And PPE Demand Will Unlock New Markets
Ansell’s fair value has been revised down as the consensus Analyst Price Target fell from A$36.15 to A$35.15, primarily reflecting a sharp increase in the company’s Future P/E ratio despite a stable discount rate. What's in the News Ansell's Board authorized a share buyback plan.Narrative Update • Aug 27
Acquisitions And New Launches Will Streamline Global Operations
Ansell’s consensus price target has increased slightly, primarily reflecting a higher future P/E despite a notable downgrade in revenue growth forecasts, resulting in a new fair value of A$36.21. What's in the News Board authorized a buyback plan.Analysis Article • Jul 05
Ansell (ASX:ANN) Has More To Do To Multiply In Value Going Forward
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...Analysis Article • Jun 17
Ansell Limited's (ASX:ANN) P/E Is On The Mark
Ansell Limited's ( ASX:ANN ) price-to-earnings (or "P/E") ratio of 25.6x might make it look like a sell right now...Analysis Article • May 23
Ansell (ASX:ANN) Could Easily Take On More Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Narrative • May 17
Acquisitions And New Launches Will Streamline Global Operations
Strategic acquisitions and supply chain diversification are bolstering revenue growth, enhancing margins, and mitigating risk.Analysis Article • Apr 03
Ansell Limited (ASX:ANN) Shares Could Be 48% Below Their Intrinsic Value Estimate
Key Insights Ansell's estimated fair value is AU$56.40 based on 2 Stage Free Cash Flow to Equity Current share price of...Analysis Article • Mar 01
Ansell (ASX:ANN) Has More To Do To Multiply In Value Going Forward
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Feb 11
Ansell (ASX:ANN) Could Easily Take On More Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Oct 22
Here's Why Ansell Limited's (ASX:ANN) CEO Compensation Is The Least Of Shareholders' Concerns
Key Insights Ansell will host its Annual General Meeting on 23rd of October Total pay for CEO Neil Salmon includes...Analysis Article • Jun 18
Ansell Limited's (ASX:ANN) P/E Is On The Mark
When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") below 18x, you may consider...Analysis Article • Mar 14
We Think Ansell (ASX:ANN) Can Stay On Top Of Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Jan 16
Ansell Limited's (ASX:ANN) Prospects Need A Boost To Lift Shares
With a price-to-earnings (or "P/E") ratio of 13x Ansell Limited ( ASX:ANN ) may be sending bullish signals at the...Analysis Article • Dec 14
Returns On Capital At Ansell (ASX:ANN) Have Stalled
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Nov 29
Ansell Limited's (ASX:ANN) Intrinsic Value Is Potentially 68% Above Its Share Price
Key Insights Ansell's estimated fair value is AU$39.36 based on 2 Stage Free Cash Flow to Equity Ansell is estimated to...Analysis Article • Sep 06
Ansell (ASX:ANN) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Jul 15
Returns At Ansell (ASX:ANN) Are On The Way Up
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Analysis Article • Apr 07
Ansell (ASX:ANN) Shareholders Will Want The ROCE Trajectory To Continue
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...Analysis Article • Mar 09
Estimating The Fair Value Of Ansell Limited (ASX:ANN)
Key Insights The projected fair value for Ansell is AU$28.29 based on 2 Stage Free Cash Flow to Equity Current share...Analysis Article • Dec 22
Ansell's (ASX:ANN) Returns On Capital Are Heading Higher
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Analysis Article • Dec 09
Is Ansell (ASX:ANN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Oct 18
Ansell Limited (ASX:ANN) Shares Could Be 36% Below Their Intrinsic Value Estimate
In this article we are going to estimate the intrinsic value of Ansell Limited ( ASX:ANN ) by taking the expected...Analysis Article • Sep 19
Returns At Ansell (ASX:ANN) Are On The Way Up
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • Aug 25
Ansell (ASX:ANN) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Aug 06
Ansell (ASX:ANN) Ticks All The Boxes When It Comes To Earnings Growth
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • May 08
Ansell Limited's (ASX:ANN) Intrinsic Value Is Potentially 97% Above Its Share Price
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Ansell Limited...Analysis Article • Apr 20
Ansell (ASX:ANN) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Shareholder Returns
| ANN | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 5.6% | 1.9% | 1.7% |
| 1Y | -4.7% | -42.0% | 2.2% |
Return vs Industry: ANN exceeded the Australian Medical Equipment industry which returned -42% over the past year.
Return vs Market: ANN underperformed the Australian Market which returned 2.2% over the past year.
Price Volatility
| ANN volatility | |
|---|---|
| ANN Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 10.2% |
| Market Average Movement | 10.1% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 4.0% |
Stable Share Price: ANN has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: ANN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 15,000 | Nathalie Ahlstrom | www.ansell.com |
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.
Ansell Limited Fundamentals Summary
| ANN fundamental statistics | |
|---|---|
| Market cap | AU$4.08b |
| Earnings (TTM) | AU$192.16m |
| Revenue (TTM) | AU$2.85b |
21.2x
P/E Ratio1.4x
P/S RatioIs ANN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANN income statement (TTM) | |
|---|---|
| Revenue | US$2.01b |
| Cost of Revenue | US$1.16b |
| Gross Profit | US$847.50m |
| Other Expenses | US$712.10m |
| Earnings | US$135.40m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 24, 2026
| Earnings per share (EPS) | 0.97 |
| Gross Margin | 42.16% |
| Net Profit Margin | 6.74% |
| Debt/Equity Ratio | 36.6% |
How did ANN perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield58%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/13 19:48 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ansell Limited is covered by 24 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Stuart Roberts | Bell Potter |
| Lyanne Harrison | BofA Global Research |